Cerevel Therapeutics Holdings Inc CERE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/23/24 EDT
41.63quote price arrow down-0.02 (-0.05%)
Volume
1,087,077
52 week range
19.59 - 43.59
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close41.63
  • 52 Week High43.59
  • 52 Week High Date02/15/24
  • 52 Week Low19.59
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap7.585B
  • Shares Out182.19M
  • 10 Day Average Volume1.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-1.82

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close41.63
  • 52 Week High43.59
  • 52 Week High Date02/15/24
  • 52 Week Low19.59
  • 52 Week Low Date10/04/23
  • Market Cap7.585B
  • Shares Out182.19M
  • 10 Day Average Volume1.08M
  • Dividend-
  • Dividend Yield-
  • Beta1.42
  • YTD % Change-1.82

RATIOS/PROFITABILITY

  • EPS (TTM)-2.72
  • P/E (TTM)-15.30
  • Fwd P/E (NTM)-16.05
  • EBITDA (TTM)-484.523M
  • ROE (TTM)-92.45%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)59.87%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cerevel Therapeutics Holdings Inc

 

Profile

MORE
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including...
N. Coles Jr., M.D.
Chairperson of the Board of Directors
Ronald Renaud Jr.
President, Chief Executive Officer, Member of the Board
Susan Altschuller Ph.D.
Chief Financial Officer
Address
222 Jacobs Street, Suite 200
Cambridge, MA
02141
United States

Top Peers

SYMBOLLASTCHG%CHG
VKTX
Viking Therapeutics Inc
61.57-1.44-2.29%
PCVX
Vaxcyte Inc
69.27-2.09-2.93%
RVMD
Revolution Medicines Inc
38.13-1.64-4.12%
CYTK
Cytokinetics Inc
48.98-10.25-17.31%
ROIV
Roivant Sciences Ltd
10.94-0.35-3.10%